ZA879458B - Medicaments - Google Patents
MedicamentsInfo
- Publication number
- ZA879458B ZA879458B ZA879458A ZA879458A ZA879458B ZA 879458 B ZA879458 B ZA 879458B ZA 879458 A ZA879458 A ZA 879458A ZA 879458 A ZA879458 A ZA 879458A ZA 879458 B ZA879458 B ZA 879458B
- Authority
- ZA
- South Africa
- Prior art keywords
- methyl
- medicaments
- carbazol
- imidazol
- solvates
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- -1 2-methyl-1H-imidazol-1-yl Chemical group 0.000 abstract 1
- 208000020401 Depressive disease Diseases 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Emergency Protection Circuit Devices (AREA)
- Connection Of Batteries Or Terminals (AREA)
- Electrotherapy Devices (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB868630071A GB8630071D0 (en) | 1986-12-17 | 1986-12-17 | Medicaments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA879458B true ZA879458B (en) | 1988-11-30 |
Family
ID=10609112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA879458A ZA879458B (en) | 1986-12-17 | 1987-12-17 | Medicaments |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4835173A (cs) |
| EP (1) | EP0276559B1 (cs) |
| JP (1) | JP2732844B2 (cs) |
| KR (1) | KR880007073A (cs) |
| AT (1) | ATE79031T1 (cs) |
| AU (1) | AU608794B2 (cs) |
| CY (1) | CY1693A (cs) |
| DE (1) | DE3780940T2 (cs) |
| DK (1) | DK662787A (cs) |
| ES (1) | ES2051754T3 (cs) |
| GB (1) | GB8630071D0 (cs) |
| GR (1) | GR3005682T3 (cs) |
| HK (1) | HK36593A (cs) |
| IE (1) | IE60135B1 (cs) |
| IL (1) | IL84844A0 (cs) |
| NZ (1) | NZ222949A (cs) |
| PH (1) | PH25503A (cs) |
| ZA (1) | ZA879458B (cs) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0278173B1 (en) * | 1986-12-17 | 1993-11-03 | Glaxo Group Limited | Use of heterocyclic derivatives in the treatment of depressions |
| US5246941A (en) * | 1986-12-17 | 1993-09-21 | Glaxo Group Limited | Method for the treatment of depression |
| GB8820653D0 (en) * | 1988-09-01 | 1988-10-05 | Glaxo Group Ltd | Medicaments |
| US5221687A (en) * | 1988-09-01 | 1993-06-22 | Glaxo Group Limited | Medicaments |
| US5180728A (en) * | 1989-09-25 | 1993-01-19 | Fujisawa Pharmaceutical Company, Ltd. | Pyrimidoindole derivatives and processes for preparation thereof |
| US5225407A (en) * | 1990-02-22 | 1993-07-06 | Glaxo Group Limited | 5-HT3 receptor antagonists for the treatment of autism |
| AU2295792A (en) * | 1991-06-26 | 1993-01-25 | Sepracor, Inc. | Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron |
| JP2002538102A (ja) | 1999-03-01 | 2002-11-12 | セプラコア インコーポレーテッド | 光学的に純粋なｒ（＋）オンダンセトロンを使用する無呼吸および無呼吸障害の治療方法 |
| HUP0401239A2 (hu) * | 2000-10-30 | 2004-12-28 | Teva Pharmaceutical Industries Ltd. | Ondansetron-hidroklorid új kristályos és szolvát formái, valamint eljárások az előállításukra |
| EP1207160A1 (en) * | 2000-11-20 | 2002-05-22 | Hanmi Pharm. Co., Ltd. | Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one |
| PL368837A1 (en) * | 2001-01-11 | 2005-04-04 | Teva Pharmaceutical Industries Ltd. | An improved process for preparing pure ondansetron hydrochloride dihydrate |
| US20020115707A1 (en) * | 2001-01-11 | 2002-08-22 | Rami Lidor-Hadas | Process for preparing pure ondansetron hydrochloride dihydrate |
| CN1665823A (zh) * | 2002-04-29 | 2005-09-07 | 特瓦药厂有限公司 | 制备1,2,3,9－四氢－9－甲基－3－[(2－甲基－1h－咪唑－1－基)甲基]－4h－咔唑－4－酮的方法 |
| US20050131045A1 (en) * | 2002-04-30 | 2005-06-16 | Judith Aronhime | Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them |
| EP1465887A1 (en) * | 2002-04-30 | 2004-10-13 | Teva Gyogyszergyar Reszvenytarsasag | Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating nausea using them |
| HU225885B1 (en) * | 2002-10-17 | 2007-11-28 | Richter Gedeon Nyrt | Process for producing ondansetron hydrochlorid dihydrate of high purity |
| US20110034442A1 (en) * | 2007-08-08 | 2011-02-10 | Jaun Jose Legarda Ibanez | Use and Methods of Use for an Antagonist of the Serotin3 Receptor (5-HT3) and a Selective Modulator of Chloride Channels for the Treatment of Addiction to or Dependence on Medicines/Drugs or Nervous System Disorders |
| JP7515407B2 (ja) * | 2018-06-21 | 2024-07-12 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | ニコチンアミドアデニンジヌクレオチド（ｎａｄ＋）前駆体及び少なくとも１種のケトン又はケトン前駆体を使用する組成物及び方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN158970B (cs) * | 1981-06-09 | 1987-02-28 | Ici Plc | |
| FR2561244B1 (fr) * | 1984-01-25 | 1988-03-04 | Glaxo Group Ltd | Composes heterocycliques du type tetrahydrocarbazolone, procede pour leur preparation et composition pharmaceutique les comprenant |
| GB8401888D0 (en) * | 1984-01-25 | 1984-02-29 | Glaxo Group Ltd | Heterocyclic compounds |
| EP0385517B1 (en) * | 1985-03-14 | 1993-04-14 | BEECHAM GROUP plc | Medicaments for the treatment of emesis |
| GB8516083D0 (en) * | 1985-06-25 | 1985-07-31 | Glaxo Group Ltd | Heterocyclic compounds |
| GB8518743D0 (en) * | 1985-07-24 | 1985-08-29 | Glaxo Group Ltd | Heterocyclic compounds |
| HU202108B (en) * | 1986-07-30 | 1991-02-28 | Sandoz Ag | Process for producing pharmaceutical compositions containing serotonine antqgonistic derivatives of indol-carboxylic acid or imidazolyl-methyl-carbazol |
-
1986
- 1986-12-17 GB GB868630071A patent/GB8630071D0/en active Pending
-
1987
- 1987-12-16 PH PH36241A patent/PH25503A/en unknown
- 1987-12-16 EP EP87311082A patent/EP0276559B1/en not_active Expired - Lifetime
- 1987-12-16 AT AT87311082T patent/ATE79031T1/de not_active IP Right Cessation
- 1987-12-16 DE DE8787311082T patent/DE3780940T2/de not_active Expired - Lifetime
- 1987-12-16 JP JP62318455A patent/JP2732844B2/ja not_active Expired - Lifetime
- 1987-12-16 AU AU82617/87A patent/AU608794B2/en not_active Ceased
- 1987-12-16 IE IE341587A patent/IE60135B1/en not_active IP Right Cessation
- 1987-12-16 IL IL84844A patent/IL84844A0/xx not_active IP Right Cessation
- 1987-12-16 NZ NZ222949A patent/NZ222949A/en unknown
- 1987-12-16 DK DK662787A patent/DK662787A/da not_active Application Discontinuation
- 1987-12-16 ES ES87311082T patent/ES2051754T3/es not_active Expired - Lifetime
- 1987-12-16 US US07/133,887 patent/US4835173A/en not_active Expired - Lifetime
- 1987-12-17 ZA ZA879458A patent/ZA879458B/xx unknown
- 1987-12-17 KR KR870014390A patent/KR880007073A/ko not_active Ceased
-
1992
- 1992-09-10 GR GR920402010T patent/GR3005682T3/el unknown
-
1993
- 1993-04-15 HK HK365/93A patent/HK36593A/en not_active IP Right Cessation
-
1994
- 1994-01-14 CY CY169394A patent/CY1693A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1693A (en) | 1994-01-14 |
| IE873415L (en) | 1988-06-17 |
| ATE79031T1 (de) | 1992-08-15 |
| GB8630071D0 (en) | 1987-01-28 |
| PH25503A (en) | 1991-07-24 |
| DE3780940D1 (de) | 1992-09-10 |
| ES2051754T3 (es) | 1994-07-01 |
| EP0276559B1 (en) | 1992-08-05 |
| IE60135B1 (en) | 1994-06-01 |
| JPS63165314A (ja) | 1988-07-08 |
| HK36593A (en) | 1993-04-23 |
| JP2732844B2 (ja) | 1998-03-30 |
| DE3780940T2 (de) | 1992-12-24 |
| NZ222949A (en) | 1997-06-24 |
| DK662787D0 (da) | 1987-12-16 |
| EP0276559A2 (en) | 1988-08-03 |
| KR880007073A (ko) | 1988-08-26 |
| AU8261787A (en) | 1988-06-23 |
| IL84844A0 (en) | 1988-06-30 |
| DK662787A (da) | 1988-06-18 |
| EP0276559A3 (en) | 1989-10-18 |
| GR3005682T3 (cs) | 1993-06-07 |
| AU608794B2 (en) | 1991-04-18 |
| US4835173A (en) | 1989-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA879458B (en) | Medicaments | |
| PH25126A (en) | 1,5-diaryl-3-substituted pyrazoles pharmaceutical compositions and use | |
| IL116203A (en) | Pharmaceutical compositions for the treatment of emesis comprising (2s, 3s) -3-(2-methoxybenzylamino)-2-phenylpiperidine and ondansetron | |
| ES2032503T3 (es) | Medicamento para la zona de la cavidad bucal. (reserva del art. 167.2 cpe). | |
| EP0363415A4 (en) | Compounds for the treatment of alzheimer's disease | |
| PL268927A1 (en) | Method of obtaining novel derivatives of benzimidazole | |
| EP0276536A3 (en) | Use of buspirone for the improvement of short term memory | |
| GR3004252T3 (cs) | ||
| OA09194A (en) | "Insecticidal treatment and compositions therefor". | |
| IE873414L (en) | Medicament for dementia | |
| HU902004D0 (en) | New trombolitic preparations | |
| IL86028A0 (en) | Novel pyrrolidine-2-(1,3-dicarbonyl)derivatives,their preparation,agents containing them,and their use | |
| IL90499A0 (en) | Therapeutic uses of 2',5'-oligoadenylates | |
| NZ223293A (en) | Beta-alkyl melatonins and pharmaceutical compositions | |
| IE873231L (en) | Medicaments | |
| AU8050587A (en) | Dividable capsule | |
| EP0495226A3 (en) | 3-aryl-5-alkylthio-4h-1,2,4-triazoles for treatment of hyperreflexia due to spinal trauma | |
| MY103584A (en) | 8(alpha)-acylaminoergoline, its preparation and pharmaceutical compositions containing it | |
| NZ223203A (en) | Herbicidal compositions containing tetrahydrophthalimides and 1,3,5-triazin-2-yl-urea derivatives | |
| FI882378A7 (fi) | Tandlaekarens patientstol. | |
| 李虎容 et al. | OCCLUSAL CONSIDERATION FOR IMPLANTS | |
| RU1833744C (en) | Device for individual taking of v,n,pozdnyakov's medicinal means | |
| IT8919216A0 (it) | Dispositivo per la cura chirurgica dell'astigmatismo. | |
| IL106709A0 (en) | Therapeutic uses of 2',5'-oligoadenylates | |
| ITMI931777A0 (it) | Nuovi agenti per l'ossigenazione extracorporea del sangue |